The estimated Net Worth of Jennifer Streeter is at least 300 千$ dollars as of 18 August 2022. Ms Streeter owns over 50,000 units of Perspective Therapeutics Inc stock worth over 33,769$ and over the last 7 years she sold ISR stock worth over 0$. In addition, she makes 266,349$ as COO & VP of HR at Perspective Therapeutics Inc.
Ms has made over 2 trades of the Perspective Therapeutics Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she exercised 50,000 units of ISR stock worth 21,500$ on 18 August 2022.
The largest trade she's ever made was exercising 50,000 units of Perspective Therapeutics Inc stock on 18 August 2022 worth over 21,500$. On average, Ms trades about 9,063 units every 2 days since 2017. As of 18 August 2022 she still owns at least 87,940 units of Perspective Therapeutics Inc stock.
You can see the complete history of Ms Streeter stock trades at the bottom of the page.
Jennifer Streeter is the COO & VP of HR at Perspective Therapeutics Inc.
As the COO & VP of HR of Perspective Therapeutics Inc, the total compensation of Ms Streeter at Perspective Therapeutics Inc is 266,349$. There are 5 executives at Perspective Therapeutics Inc getting paid more, with Lori Woods having the highest compensation of 416,524$.
Ms Streeter is 51, she's been the COO & VP of HR of Perspective Therapeutics Inc since . There are 9 older and 7 younger executives at Perspective Therapeutics Inc. The oldest executive at Perspective Therapeutics Inc is Philip Vitale, 73, who is the Independent Director.
Jennifer's mailing address filed with the SEC is 350 HILLS STREET SUITE 106, , RICHLAND, WA, 99354.
Over the last 18 years, insiders at Perspective Therapeutics Inc have traded over 0$ worth of Perspective Therapeutics Inc stock and bought 1,651,741 units worth 855,397$ . The most active insiders traders include Lori A Woods、Thomas C Lavoy、Dwight William Babcock. On average, Perspective Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of 14,501$. The most recent stock trade was executed by Lori A Woods on 13 April 2023, trading 187,500 units of ISR stock currently worth 114,375$.
Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium Blu brachytherapy seeds, which are expanding brachytherapy treatment options throughout the body.
Perspective Therapeutics Inc executives and other stock owners filed with the SEC include: